Scientists test new Shot's safety with common pills
NCT ID NCT07068841
Summary
This early study aimed to see if a new injectable drug called Y-3 interacts with three common oral medications: repaglinide (for diabetes), warfarin (a blood thinner), and omeprazole (for heartburn). Researchers enrolled 24 healthy Chinese participants to measure how the body processes these drugs when taken with and without Y-3. The goal was to gather safety data to help write future instructions for using Y-3.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-DRUG INTERACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
Conditions
Explore the condition pages connected to this study.